Crossref
The use of pharmacologic agents in the management of temporomandibular joint disorder
Frontiers of Oral and Maxillofacial Medicine · 2022
DOI: 10.21037/fomm-20-37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Oral and Maxillofacial Medicine, 2022. Verfasst von Chad Dammling und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dammling, C., Abramowicz, S., & Kinard, B. (2022). The use of pharmacologic agents in the management of temporomandibular joint disorder. Frontiers of Oral and Maxillofacial Medicine. https://doi.org/10.21037/fomm-20-37
Vancouver
Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Frontiers of Oral and Maxillofacial Medicine. 2022. doi:10.21037/fomm-20-37
BibTeX
@article{Dammling2022,
author = {Dammling, Chad and Abramowicz, Shelly and Kinard, Brian},
title = {The use of pharmacologic agents in the management of temporomandibular joint disorder},
journal = {Frontiers of Oral and Maxillofacial Medicine},
year = {2022},
doi = {10.21037/fomm-20-37}
}
EUVIMED